99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02134613|
Recruitment Status : Unknown
Verified May 2016 by Bianca Gutfilen, Universidade Federal do Rio de Janeiro.
Recruitment status was: Recruiting
First Posted : May 9, 2014
Last Update Posted : May 27, 2016
|Condition or disease||Intervention/treatment||Phase|
|Psoriatic Arthritis Arthritis||Other: 99mTc-anti-TNF-alpha Scintigraphy||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity|
|Study Start Date :||January 2009|
|Estimated Primary Completion Date :||July 2017|
|Estimated Study Completion Date :||December 2017|
Experimental: anti-TNF-alpha scintigraphy
99mTc-anti-TNF-alpha Scintigraphy will be compared with MRI results, analysed and discussed by physicians who are in charge of the patients.
Other: 99mTc-anti-TNF-alpha Scintigraphy
99mTc-anti-TNF-alpha Scintigraphy will be analysed and discussed by physicians who are in charge of the patients.
- Percentage of Participants with 99mTc-anti-TNF-alpha joint and skin uptake [ Time Frame: 1 week ]
- Percentage of Participants with decreased 99mTc-anti-TNF-alpha uptake after follow-up [ Time Frame: 5 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02134613
|Contact: Bianca Gutfilen, PhD||55 21 email@example.com|
|Contact: Sergio A Souza, PhD||55 21 firstname.lastname@example.org|
|Hospital Universitário Clementino Fraga Filho||Recruiting|
|Rio de Janeiro, RJ, Brazil, 21941-913|
|Principal Investigator: Bianca Gutfilen, PhD|
|Principal Investigator:||Bianca Gutfilen, PhD||UFRJ|